+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Bile Duct Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bile Duct Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neuroendocrine Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Oropharyngeal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Oropharyngeal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Colorectal Cancer (CRC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Cancer (CRC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Renal cell carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Renal cell carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anaplastic Astrocytoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anaplastic Astrocytoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epithelial Ovarian Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Epithelial Ovarian Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Fallopian Tube Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Fallopian Tube Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neuroendocrine Tumours - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuroendocrine Tumours - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Oligodendroglioma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Oligodendroglioma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more